(Q37014626)

17 August 2017

1 reference

title

Collaborative depression care, screening, diagnosis and specificity of depression treatments in the primary care setting (English)

1 reference

Jeanne Leventhal Alexander

17 August 2017

1 reference

series ordinal

1

object named as

Jeanne Leventhal Alexander

1 reference

17 August 2017

4

Enid M Hunkeler

1 reference

17 August 2017

Gregg Richardson

2

1 reference

17 August 2017

Lydia Grypma

series ordinal

3

1 reference

17 August 2017

publication date

1 November 2007

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

17 August 2017

published in

1 reference

17 August 2017

volume

7

1 reference

17 August 2017

issue

11 Suppl

1 reference

17 August 2017

page(s)

S59-80

1 reference

Comorbid painful physical symptoms and depression: prevalence, work loss, and help seeking.

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

The medical management of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Impact of antidepressant drug adherence on comorbid medication use and resource utilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Prevalence, nature, and comorbidity of depressive disorders in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Awareness, diagnosis, and treatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

The National Depressive and Manic-Depressive Association consensus statement on the undertreatment of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians' diagnoses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Prevalence and treatment of depression in a hospital department of internal medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Taking an evidence-based model of depression care from research to practice: making lemonade out of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

The cost-utility of screening for depression in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Screening for depression in primary care: recommendation statement from the Canadian Task Force on Preventive Health Care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Screening for depression in adults: a summary of the evidence for the U.S. Preventive Services Task Force

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Improving primary care for depression in late life: the design of a multicenter randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Impacting late life depression: integrating a depression intervention into primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

One size fits some: the impact of patient treatment attitudes on the cost-effectiveness of a depression primary-care intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Physicians' satisfaction with a collaborative disease management program for late-life depression in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Translating evidence-based depression management services to community-based primary care practices

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Post-MI psychiatric syndromes: six unanswered questions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Prediction of depressive disorder following myocardial infarction data from the Myocardial INfarction and Depression-Intervention Trial (MIND-IT).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Improving depression care in patients with diabetes and multiple complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Treatment effects of antidepressants in patients with post-stroke depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Depression after stroke: a review of the evidence base to inform the development of an integrated care pathway. Part 1: Diagnosis, frequency and impact

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Cognitive reactivity to sad mood provocation and the prediction of depressive relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Screening tools for depression in primary care: the effects of culture, gender, and somatic symptoms on the detection of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Test of item-response bias in the CES-D scale. experience from the New Haven EPESE study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Using the Patient Health Questionnaire-9 to measure depression among racially and ethnically diverse primary care patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Validity and utility of the Japanese version of the WHO-Five Well-Being Index in the context of detecting suicidal ideation in elderly community residents

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Screening for depression in primary care: will one or two items suffice?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

The PHQ-9: validity of a brief depression severity measure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Identifying depression in primary care: a comparison of different methods in a prospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Responsiveness of the PHQ-9 to Psychopharmacological Depression Treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Enduring effects for cognitive behavior therapy in the treatment of depression and anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Reducing relapse and recurrence in unipolar depression: a comparative meta-analysis of cognitive-behavioral therapy's effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Mindfulness-based cognitive therapy for residual depressive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

How does cognitive therapy prevent depressive relapse and why should attentional control (mindfulness) training help?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Mindfulness-based cognitive therapy for depression: replication and exploration of differential relapse prevention effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

21 January 2018

Neurobiology of exercise

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

A randomised, controlled study on the effects of a short-term endurance training programme in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Cardiovascular fitness, cortical plasticity, and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Neurocognitive aging and cardiovascular fitness: recent findings and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Ageing, fitness and neurocognitive function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Physical activity increases mRNA for brain-derived neurotrophic factor and nerve growth factor in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Effect of a randomized, controlled trial of exercise on mood and physical function in individuals with fibromyalgia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Randomized trial of physical exercise alone or combined with bright light on mood and health-related quality of life

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Factors associated with climacteric symptoms and the use of hormone replacement therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Yearlong physical activity and depressive symptoms in older Japanese adults: cross-sectional data from the Nakanojo study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Exercise therapy for depression in middle-aged and older adults: predictors of early dropout and treatment failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

The acute antipanic activity of aerobic exercise

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Anxiety modulation by the heart? Aerobic exercise and atrial natriuretic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Muscle relaxation therapy for anxiety disorders: it works but how?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Medical patients' attitudes toward emotional problems and their treatment. What do they really want?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

The impact of patient participation on adherence and clinical outcome in primary care of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Barriers to psychotherapy among depressed and nondepressed primary care patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Lay people's attitudes to treatment of depression: results of opinion poll for Defeat Depression Campaign just before its launch

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Treatment preferences among depressed primary care patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Patients' perspectives on the management of emotional distress in primary care settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Assessing effectiveness of treatment of depression in primary care. Partially randomised preference trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Adherence by medical-surgical inpatients to recommendations for outpatient psychiatric treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

A meta-analysis of psychotherapy dropout

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Barriers to seeking treatment for major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Distressed women's clinic patients: preferences for mental health treatments and perceived obstacles

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Report by the ACNP Task Force on response and remission in major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Definition and epidemiology of treatment-resistant depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Lithium and tricyclic augmentation of fluoxetine treatment for resistant major depression: a double-blind, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

The Work and Social Adjustment Scale: a simple measure of impairment in functioning.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Problem-solving therapy versus supportive therapy in geriatric major depression with executive dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

A randomised controlled trial and cost analysis of problem-solving treatment for emotional disorders given by community nurses in primary care.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Randomised controlled trial of problem solving treatment, antidepressant medication, and combined treatment for major depression in primary care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Comparative effects of short-term psychodynamic psychotherapy and cognitive-behavioral therapy in depression: a meta-analytic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

What is the place of psychological treatments in mood disorders?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Randomized trial of behavioral activation, cognitive therapy, and antidepressant medication in the acute treatment of adults with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Effects of enhanced depression treatment on diabetes self-care

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

A meta-analysis of the effects of cognitive therapy in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

A meta-(re)analysis of the effects of cognitive therapy versus 'other therapies' for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Changes in cognitive content during and following cognitive therapy for recurrent depression: substantial and enduring, but not predictive of change in depressive symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Validity of controlled clinical trials of psychotherapy: findings from the NIMH Treatment of Depression Collaborative Research Program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

A systematic review of research findings on the efficacy of interpersonal therapy for depressive disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Toward molecular diagnostics of mood disorders in psychiatry

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Pharmacogenomics and cardiovascular drugs: need for integrated biological system with phenotypes and proteomic markers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

National Institute of Mental Health Treatment of Depression Collaborative Research Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Randomized trial of weekly, twice-monthly, and monthly interpersonal psychotherapy as maintenance treatment for women with recurrent depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Effects of adding cognitive therapy to fluoxetine dose increase on risk of relapse and residual depressive symptoms in continuation treatment of major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Cognitive change process during group cognitive behaviour therapy for depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Can depression be de-medicalized in the 21st century: scientific revolutions, counter-revolutions and the magnetic field of normal science

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Cognitive therapy vs medications in the treatment of moderate to severe depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

The interaction of stressful life events and a serotonin transporter polymorphism in the prediction of episodes of major depression: a replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Effectiveness of a Minimal Intervention for Stress-related mental disorders with Sick leave (MISS); study protocol of a cluster randomised controlled trial in general practice [ISRCTN43779641].

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Revenge of the "sit": how lifestyle impacts neuronal and cognitive health through molecular systems that interface energy metabolism with neuronal plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Neuropeptides in anxiety and depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Voluntary exercise and clomipramine treatment elevate prepro-galanin mRNA levels in the locus coeruleus in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Prepro-galanin messenger RNA levels are increased in rat locus coeruleus after treadmill exercise training

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Effects of exercise on gene-expression profile in the rat hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Effects of beta-adrenoreceptor blockade during chronic exercise on contextual fear conditioning and mRNA for galanin and brain-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-regression analysis of randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Exercise and the treatment of clinical depression in adults: recent findings and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Effects of chronic activity wheel running and imipramine on masculine copulatory behavior after olfactory bulbectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Compulsive exercise acutely upregulates rat hippocampal brain-derived neurotrophic factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

The effects of training and detraining on memory, neurotrophins and oxidative stress markers in rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Exercise differentially regulates synaptic proteins associated to the function of BDNF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Central administration of IGF-I and BDNF leads to long-lasting antidepressant-like effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Antidepressant-like effect of brain-derived neurotrophic factor (BDNF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Role of neurotrophic factors in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Protective effect of brain-derived neurotrophic factor on pancreatic islets in obese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Brain-derived neurotrophic factor (BDNF) and food intake regulation: a minireview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Neuroplasticity and cellular resilience in mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

CREB: a major mediator of neuronal neurotrophin responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

A neurotrophic model for stress-related mood disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Galanin in the brain: chemoarchitectonics and brain cartography--a historical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Pharmacological evidence supporting a role for galanin in cognition and affect

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Biological actions of galanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Association of galanin haplotypes with alcoholism and anxiety in two ethnically distinct populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Galanin as a modulator of anxiety and depression and a therapeutic target for affective disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

A role for galanin in antidepressant actions with a focus on the dorsal raphe nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Anxiolytic activity of atrial natriuretic peptide in patients with panic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

High plasma levels of N-terminal pro-atrial natriuretic peptide associated with low anxiety in severe heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Fluid balance in patients with chronic renal failure assessed with N-terminal proatrial natriuretic peptide, atrial natriuretic peptide and ultrasonography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Atrial natriuretic factor inhibits the CRH-stimulated secretion of ACTH and cortisol in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Central and peripheral administration of atriopeptin is anxiolytic in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Running enhances neurogenesis, learning, and long-term potentiation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

OMICS-driven biomarker discovery in nutrition and health

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Nutrigenomics: integrating genomic approaches into nutrition research

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

The case for strategic international alliances to harness nutritional genomics for public and personal health

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Nutrigenomics: the Rubicon of molecular nutrition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Omega-3 fatty acids and antioxidants in neurological and psychiatric diseases: an overview.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Paleolithic nutrition. A consideration of its nature and current implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Dietary intake of long-chain polyunsaturated fatty acids during the paleolithic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Overview of evolutionary aspects of omega 3 fatty acids in the diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Effects of an Indo-Mediterranean Diet on the Omega-6/Omega-3 Ratio in Patients at High Risk of Coronary Artery Disease: The Indian Paradox

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Mechanisms of action of docosahexaenoic acid in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Alterations in brain function after loss of docosahexaenoate due to dietary restriction of n-3 fatty acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Lipid signaling: sleep, synaptic plasticity, and neuroprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Docosahexaenoic acid (22:6n-3) enrichment of membrane phospholipids increases gap junction coupling capacity in cultured astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Synaptic lipid signaling: significance of polyunsaturated fatty acids and platelet-activating factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Neuron-astrocyte interactions: partnership for normal function and disease in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Connexins and gap junctional communication in astrocytes are targets for neuroglial interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Role of gap junctional coupling in astrocytic networks in the determination of global ischaemia-induced oxidative stress and hippocampal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

The influence of long chain polyunsaturate supplementation on docosahexaenoic acid and arachidonic acid in baboon neonate central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Neurologic condition of healthy term infants at 18 months: positive association with venous umbilical DHA status and negative association with umbilical trans-fatty acids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Growth and development in preterm infants fed long-chain polyunsaturated fatty acids: a prospective, randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

n-3 polyunsaturated fatty acid deprivation in rats decreases frontal cortex BDNF via a p38 MAPK-dependent mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Biochemical and functional effects of prenatal and postnatal omega 3 fatty acid deficiency on retina and brain in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Associations between cod liver oil use and symptoms of depression: the Hordaland Health Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Fish consumption and depressive symptoms in the general population in Finland.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Omega 3 fatty acids in bipolar disorder: a preliminary double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Addition of omega-3 fatty acid to maintenance medication treatment for recurrent unipolar depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Omega-3 fatty acids in major depressive disorder. A preliminary double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Efficacy of ethyl-eicosapentaenoic acid in bipolar depression: randomised double-blind placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Effect of maternal docosahexaenoic acid supplementation on postpartum depression and information processing

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Double-blind, randomized, placebo-controlled trials of ethyl-eicosapentanoate in the treatment of bipolar depression and rapid cycling bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Randomised double-blind placebo-controlled trial of fish oil in the treatment of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Is low dietary intake of omega-3 fatty acids associated with depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Do essential fatty acids have a role in the treatment of depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Associations of hormones and menopausal status with depressed mood in women with no history of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Omega-3 fatty acids in the treatment of psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Omega-3 polyunsaturated fatty acids and depression: a review of the evidence and a methodological critique

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Omega-3 fatty acid deficiency in major depressive disorder is caused by the interaction between diet and a genetically determined abnormality in phospholipid metabolism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

A vegetable to meat consumption ratio as a relevant factor determining cancer preventive diet. The Mediterranean versus other European countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Nutrition and cancer risk: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Meat consumption and risk of colorectal cancer: a meta-analysis of prospective studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Cardioprotective effects of vegetables: is nitrate the answer?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Vitamin B(12) deficiency and depression in physically disabled older women: epidemiologic evidence from the Women's Health and Aging Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Relationship of homocysteine, folic acid and vitamin B12 with depression in a middle-aged community sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Magnesium-deficient diet alters depression- and anxiety-related behavior in mice--influence of desipramine and Hypericum perforatum extract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Magnesium and affective disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Oral Mg(2+) supplementation reverses age-related neuroendocrine and sleep EEG changes in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Magnesium deficiency in critical illness

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Magnesium in clinical medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Does magnesium have a role in the treatment of patients with coronary artery disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Magnesium and diabetes mellitus: their relation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Magnesium deficiency and osteoporosis: animal and human observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Cognitive Therapy and Pharmacotherapy for Depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Polyunsaturated fatty acids in the central nervous system: evolution of concepts and nutritional implications throughout life

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Plasma pterins and folate in late life depression: The Rotterdam Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Cognitive Therapy and Interpersonal Psychotherapy: 30 Years Later

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Acceptability of Second-Step Treatments to Depressed Outpatients: A STAR*D Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Cognitive Therapy Versus Medication in Augmentation and Switch Strategies as Second-Step Treatments: A STAR*D Report

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Cognitive behavior approach to loss of clinical effect during long-term antidepressant treatment: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Depressive, anxiety, and somatoform disorders in primary care: prevalence and recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

Exercise and brain neurotrophins

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737175.7.11S.S59

10.1586/14737175.7.11S.S59

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference